Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.68
-0.32 (-4.57%)
At close: Mar 13, 2026, 4:00 PM EDT
6.82
+0.14 (2.10%)
After-hours: Mar 13, 2026, 7:26 PM EDT
ARCT Employees
As of December 31, 2025, Arcturus Therapeutics Holdings had 111 total employees, including 106 full-time and 5 part-time employees. The number of employees decreased by 65 or -36.93% compared to the previous year.
Employees
111
Change (1Y)
-65
Growth (1Y)
-36.93%
Revenue / Employee
$739,018
Profits / Employee
-$592,640
Market Cap
189.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 111 | -65 | -36.93% | 106 | 5 |
| Dec 31, 2024 | 176 | -4 | -2.22% | 174 | 2 |
| Dec 31, 2023 | 180 | 10 | 5.88% | 180 | 0 |
| Dec 31, 2022 | 170 | -7 | -3.95% | 170 | 0 |
| Dec 31, 2021 | 177 | 59 | 50.00% | 177 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 341 |
| MediWound | 121 |
| Tenaya Therapeutics | 97 |
| Cartesian Therapeutics | 75 |
| Compugen | 74 |
| Acumen Pharmaceuticals | 61 |
| Elicio Therapeutics | 32 |
| Eledon Pharmaceuticals | 31 |
ARCT News
- 9 days ago - Arcturus Therapeutics to Attend Upcoming Investor Conference - Business Wire
- 11 days ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline Progress - Business Wire
- 25 days ago - Arcturus Therapeutics to Report Fourth Quarter and Fiscal Year 2025 Financial Results and Provide Corporate Update on March 3, 2026 - Business Wire
- 4 weeks ago - Arcturus Therapeutics: Two Catalysts, One Runway, And A Stock Priced For Failure - Seeking Alpha
- 2 months ago - Arcturus Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
- 4 months ago - Arcturus Therapeutics Holdings Inc. (ARCT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress - Business Wire